Racial Diversity in the Decline in Hepatocellular Carcinoma and Increasing Age at Diagnosis in a Primarily African American Medical Center Population
<b>Background:</b> Hepatocellular carcinoma (HCC) remains a significant global health burden, particularly among vulnerable populations. This retrospective study investigates trends in HCC incidence and age at diagnosis within an urban medical center population, focusing on the impact of...
| Published in: | Onco |
|---|---|
| Main Authors: | Gabriel Boudagh, Ahmad Alnasart, Kenan Abou Chaer, Paul Naylor, Milton Mutchnick |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-7523/5/3/30 |
Similar Items
Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
by: Saleh A. Alqahtani, et al.
Published: (2021-11-01)
by: Saleh A. Alqahtani, et al.
Published: (2021-11-01)
Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida
by: Jones PD, et al.
Published: (2019-11-01)
by: Jones PD, et al.
Published: (2019-11-01)
Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus-induced hepatocellular carcinoma
by: Ashraf Abbass Basuni, et al.
Published: (2024-03-01)
by: Ashraf Abbass Basuni, et al.
Published: (2024-03-01)
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular Carcinoma
by: Ahmed El Sabagh, et al.
Published: (2025-01-01)
by: Ahmed El Sabagh, et al.
Published: (2025-01-01)
Concept of HBV and HCV as a risk factor and prevention of viral hepatitis-related hepatocellular carcinoma
by: Athraa Falah Alshimerry, et al.
Published: (2023-01-01)
by: Athraa Falah Alshimerry, et al.
Published: (2023-01-01)
The Impact of Geography in Hepatocellular Carcinoma: A Retrospective Population Based Study
by: Irene S. Yu, et al.
Published: (2021-01-01)
by: Irene S. Yu, et al.
Published: (2021-01-01)
Hepatitis C Infection Confirmation and Fewer Visits Contribute to Improving Treatment Rates in a Predominantly African American Health Center
by: Crisshy Auguste, et al.
Published: (2024-11-01)
by: Crisshy Auguste, et al.
Published: (2024-11-01)
Racial disparity in chronic hepatitis B infection in a predominately African American urban clinic population
by: Eugene Verkhovsky, et al.
Published: (2018-12-01)
by: Eugene Verkhovsky, et al.
Published: (2018-12-01)
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
by: Alessandra Mangia, et al.
Published: (2020-08-01)
by: Alessandra Mangia, et al.
Published: (2020-08-01)
Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
by: Claire Stevens, et al.
Published: (2023-02-01)
by: Claire Stevens, et al.
Published: (2023-02-01)
Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients
by: Reham M. Dawood, et al.
Published: (2022-08-01)
by: Reham M. Dawood, et al.
Published: (2022-08-01)
HEPATOCELLULAR CARCINOMA. RECENT ADVANCES IN DIAGNOSIS AND TREATMENT
by: T. Y. Chernobrovkina, et al.
Published: (2016-03-01)
by: T. Y. Chernobrovkina, et al.
Published: (2016-03-01)
Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression
by: Helal F. Hetta, et al.
Published: (2020-07-01)
by: Helal F. Hetta, et al.
Published: (2020-07-01)
Racial Discrimination, Social Disadvantage, and Racial–Ethnic Disparities in COVID-19 Vaccine Uptake
by: Alein Y. Haro-Ramos, MPH, et al.
Published: (2023-06-01)
by: Alein Y. Haro-Ramos, MPH, et al.
Published: (2023-06-01)
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
by: Vivek Chavda, et al.
Published: (2023-09-01)
by: Vivek Chavda, et al.
Published: (2023-09-01)
Impact of differential detection of TM6SF2 rs58542926 mutation in circulating tumor DNA versus peripheral blood cells on hepatocellular carcinoma patients
by: Samar Samir Youssef, et al.
Published: (2025-06-01)
by: Samar Samir Youssef, et al.
Published: (2025-06-01)
The role of IL-4 gene polymorphism in HCV-related hepatocellular carcinoma in Egyptian patients
by: Mohy-Eldin Abd-Elfattah, et al.
Published: (2021-02-01)
by: Mohy-Eldin Abd-Elfattah, et al.
Published: (2021-02-01)
Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview
by: Mohd Suhail, et al.
Published: (2022-07-01)
by: Mohd Suhail, et al.
Published: (2022-07-01)
Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients
by: Vicky Caponigro, et al.
Published: (2023-12-01)
by: Vicky Caponigro, et al.
Published: (2023-12-01)
Economic Competition and Racial/Ethnic Disparities in Sentencing: A Test of Economic Threat Perspective
by: Christopher D’Amato, et al.
Published: (2021-06-01)
by: Christopher D’Amato, et al.
Published: (2021-06-01)
Serum soluble Toll-like receptor 4 and the risk of hepatocellular
carcinoma in hepatitis C virus patients
by: Maha Elkammah, et al.
Published: (2021-01-01)
by: Maha Elkammah, et al.
Published: (2021-01-01)
Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients
by: Abdel-Rahman Zekri, et al.
Published: (2013-09-01)
by: Abdel-Rahman Zekri, et al.
Published: (2013-09-01)
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
by: Clemens Schotten, et al.
Published: (2021-07-01)
by: Clemens Schotten, et al.
Published: (2021-07-01)
Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
by: Sara Kishta, et al.
Published: (2020-06-01)
by: Sara Kishta, et al.
Published: (2020-06-01)
Mac-2 binding protein glycosylation isomer as a potential biomarker of hepatocellular carcinoma in HCV-cured patients
by: Amr Shaaban Hanafy, et al.
Published: (2024-11-01)
by: Amr Shaaban Hanafy, et al.
Published: (2024-11-01)
Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
by: Gladys Velarde, et al.
Published: (2023-04-01)
by: Gladys Velarde, et al.
Published: (2023-04-01)
Why the racial gap in life expectancy is declining in the United States
by: Glenn Firebaugh, et al.
Published: (2014-10-01)
by: Glenn Firebaugh, et al.
Published: (2014-10-01)
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma
by: Ciniso Sylvester Shabangu, et al.
Published: (2024-03-01)
by: Ciniso Sylvester Shabangu, et al.
Published: (2024-03-01)
Main insights of genome wide association studies into HCV-related HCC
by: Inas Maged Moaz, et al.
Published: (2020-02-01)
by: Inas Maged Moaz, et al.
Published: (2020-02-01)
Assessing racial disparities in heart transplant allocations post-2018 policy change
by: Kabir Malkani, et al.
Published: (2024-09-01)
by: Kabir Malkani, et al.
Published: (2024-09-01)
Racial disparities in diabetes prevalence among cancer patients
by: Kimlin Tam Ashing, et al.
Published: (2023-01-01)
by: Kimlin Tam Ashing, et al.
Published: (2023-01-01)
Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
by: Zuzana Macek Jilkova, et al.
Published: (2021-12-01)
by: Zuzana Macek Jilkova, et al.
Published: (2021-12-01)
Racial/Ethnic Disparities in Mortality Across the Veterans Health Administration
by: Michelle S. Wong, et al.
Published: (2019-04-01)
by: Michelle S. Wong, et al.
Published: (2019-04-01)
Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma
by: Chung-Yu Huang, et al.
Published: (2024-07-01)
by: Chung-Yu Huang, et al.
Published: (2024-07-01)
Systematic review of racial and ethnic disparities pertaining treatment in mental healthcare amongst incarcerated patients
by: A. Quintão, et al.
Published: (2021-04-01)
by: A. Quintão, et al.
Published: (2021-04-01)
Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
by: Xiaoyu Liu, et al.
Published: (2022-08-01)
by: Xiaoyu Liu, et al.
Published: (2022-08-01)
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
by: Chung-Feng Huang, et al.
Published: (2024-07-01)
by: Chung-Feng Huang, et al.
Published: (2024-07-01)
Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
by: Nahla Anber, et al.
Published: (2020-02-01)
by: Nahla Anber, et al.
Published: (2020-02-01)
Racial/ethnic disparities in early‐onset colorectal cancer: implications for a racial/ethnic‐specific screening strategy
by: Ana R. Acuna‐Villaorduna, et al.
Published: (2021-03-01)
by: Ana R. Acuna‐Villaorduna, et al.
Published: (2021-03-01)
Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers
by: Chiranjeevi Gadiparthi, et al.
Published: (2019-09-01)
by: Chiranjeevi Gadiparthi, et al.
Published: (2019-09-01)
Similar Items
-
Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
by: Saleh A. Alqahtani, et al.
Published: (2021-11-01) -
Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida
by: Jones PD, et al.
Published: (2019-11-01) -
Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus-induced hepatocellular carcinoma
by: Ashraf Abbass Basuni, et al.
Published: (2024-03-01) -
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular Carcinoma
by: Ahmed El Sabagh, et al.
Published: (2025-01-01) -
Concept of HBV and HCV as a risk factor and prevention of viral hepatitis-related hepatocellular carcinoma
by: Athraa Falah Alshimerry, et al.
Published: (2023-01-01)
